Introduction
A number ofrecent investigations have shown that HLA class I antigens play a broader role in cell economy than originally described. Besides their well-known function as restricting elements in the recognition of nominal antigen-modified target cells by cytotoxic T cells (1) , HLA class I antigens regulate the proliferation of normal and malignant cells (2) (3) (4) and modulate the lysis of malignant cells by natural killer (NK)' cells (5) (6) (7) . Interest in the molecular basis for the functional properties of HLA class I antigens has provided the incentive to analyze the structural organization, the biosynthetic pathway, and the expression of these membrane bound molecules. Like their counterparts in other animal species, HLA class I antigens are composed of a 45,000 M, glycopolypeptide noncovalently associated with the 1 1,600 M, lB2-microglobulin (gB2-,') (8, 9) . The cell surface expression of HLA class I antigens is regulated at several levels. Potent transcriptional control of HLA class I genes has been shown to be mediated by the lymphokines immune interferon (IFN-y) (10) and tumor necrosis factor (11).
At the post transcriptional level, association Of 02-A with the heavy chain controls the transport of HLA class I molecules to the cell surface (8, 9) . A defect in 2-/ synthesis results in lack of HLA class I antigen cell surface expression as observed in lymphoblastoid cells Daudi; the latter cells do not express HLA class I molecules on the cell membrane, in spite ofthe synthesis of HLA class I heavy chain (12) . The defect in Daudi cells has been shown to be a point mutation in the initiation codon of 32 -L mRNA that causes low efficiency in its binding to ribosomes, with a resultant lack of protein synthesis (13) . HLA class I antigen expression by Daudi cells is reconstituted after somatic cell fusion with #2-/A cells or after B2m gene transfer (14) (15) (16) (17) . Reexpression of HLA class I antigens is associated with modifications in cellular immune recognition of the tumor cell line (17) .
Malignant transformation of melanocytes may be associated with a reduction or loss of HLA class I antigen expression (18) . To date, limited information is available regarding the molecular mechanism(s) underlying the repression of HLA class I antigen expression by melanoma cells. To 23) . Therefore, in the present study we have characterized the molecular defect in the melanoma cell line FO-1, which lacks HLA class I antigens (24) . Furthermore, we have compared the molecular mechanism(s) underlying the lack of HLA class I antigen expression by melanoma cells FO-1 to those in lymphoid cells Daudi.
Methods
Cell lines. The melanoma cell line FO-1 was cultured in Dulbecco's minimal essential medium (DMEM) (Gibco Laboratories, Grand Island, NY) supplemented with 10% FCS and 2 mM L-glutamine. The T lymphoblastoid cell line MOLT-4, the B lymphoblastoid cell lines Daudi, MANN, and WALK, and the melanoma cell line 3S5 were grown in Opti-MEM (Gibco Laboratories) medium supplemented with 5% FCS and 2 mM L-glutamine. Transfected FO-I cells were maintained in DMEM supplemented with the neomycin analogue G418 sulfate (Gibco Laboratories) (1 mg/ml). Cells were harvested by vigorous pipetting with PBS supplemented with 1 mM EDTA.
Monoclonal antibodies and conventional antisera. The MAb W6/ 32 to a monomorphic determinant expressed on #,2-j-associated HLA class I heavy chain (25) , the MAb TP25.99 to a determinant expressed on both 2-,-associated and #2-M free HLA class I heavy chain, the antihuman #2-$ MAb BBM-1 (26) and NAMB-1 (27) , the anti-HLA-DR,DQ,DP MAb Q5/13 (28) , and the anti-intercellular adhesion molecule-I (ICAM-1) MAb CL207.14 (29) were developed and characterized as described. The rabbit antiserum R5996-4 to denatured HLA class I heavy chain was developed and characterized following the methodology described by Nakamuro et al. (30) . The antimouse f2-M xenoantiserum R7038, 59-63 was developed as described by Natori et al. (31) . Purified goat anti-rabbit Ig antibodies were purchased from Jackson ImmunoResearch Laboratories, Inc., West Grove, PA.
MAbs were purified from ascitic fluid by sequential precipitation with caprylic acid and ammonium sulphate (32) . MAbs were labeled with 1251 using the iodogen method (33) . The immunoreactive fraction of the radiolabeled antibodies was at least 50%, as measured by the method of Lindmo et al. (34) .
cDNA probes and human and mouse B2m genes. The cDNA probe for HLA-B7 antigen (35) and the cDNA probe for human 2-A (36) were isolated by digestion ofthe plasmids with restriction endonuclease PstI. Thomas (47) . Blots were baked at 80°C under vacuum for 2 h and prehybridized at 65°C for 3 h in 5X SSC, 5X Denhardt's reagent, 0.2 M sodium phosphate, pH 7.0, and denatured salmon sperm DNA (100 gg/ml). Filters were hybridized for 12-16 h at 37°C in hybridization buffer containing 50% formamide and a "2P-labeled probe. After two washings at 42°C for 30 min with IX SSC, 0.1% SDS, blots were washed twice at 55°C for 30 min with 0.1 X SSC, 0.1 % SDS, dried, and autoradiographed at -70°C for 1-3 d using XAR-5 x-ray film (Eastman Kodak Co., Rochester, NY) and an intensifying screen (DuPont Co., Wilmington, DE).
DNA hybridization analysis. Genomic DNA was extracted essentially as described by Perbal (48). DNA was digested with restriction endonucleases for 24 h and then run on a 1% agarose gel containing Tris-borate-EDTA buffer. Blotting was performed according to standard procedures (49) . After electrophoresis, the gel was soaked in several volumes ofdenaturing solution (1.5 M NaCl and 0.5 M NaOH) for 1 h at room temperature and then neutralized in 1 M Tris-HCl (pH 8.0) and 1.5 M NaCl. After gel transfer, the nitrocellulose membrane was baked at 80°C for 2 h. Prehybridization, hybridization, washings, and autoradiography were performed following the same experimental conditions used for RNA hybridization analysis.
Transfection ofFO-J cells with mouse B2m gene. Transfection of melanoma cells with the 14-kb XhoI fragment containing the mouse B2m gene and with pSV2neo was performed by electroporation essentially as described (50) . Briefly, cells (2 X 107), the 14-kb XhoI DNA fragment (100 zug) and EcoRI-digested pSV2neo (5 ,ug) were suspended in I ml of cold PBS. An electroporation power supply (Bethesda Research Laboratories, Gaithersburg, MD) applied an electric pulse of 1 kV and 330 uF to the chamber containing cells. Cells were then recovered in DMEM medium supplemented with 10% FCS, seeded in eight 100-mm tissue culture dishes, and incubated at 37°C in 5% CO2. The following day, G418-sulfate was added to the medium at the final concentration of 3 mg/ml (effective concentration was -1.5 mg/ml). The concentration of G418-sulfate was reduced to 2 mg/ml after 3 d of incubation and to I mg/ml after 7 To define the nature and the extent of the abnormality, DNA from FO-1 cells was digested with XbaI, EcoRI, BglII, or HindIII and hybridized with probes derived from the human pb2m 13 clone (Fig. 4, E A and C, which were weakly stained, were expanded and characterized. To confirm co-transfection, Northern blot analysis was performed using the mouse B2m gene as probe. Both FO-1 clones A and C expressed #2-M mRNA which was not detected in FO-1 cells transfected with the pSV2neo gene alone (Fig. 5) . In a direct binding assay, FO-l clones A and C displayed a weak reactivity with '251-labeled anti-HLA class I MAb W6/32 and TP25.99 (Fig. 6) . Furthermore, SDS-PAGE analysis ofimmunoprecipitates with the MAb W6/32 (Fig. 7) from '251I-labeled FO-I clones A and C detected two components with the characteristic electrophoretic mobility of the heavy and light chain of HLA class I antigens.
The reactivity of MAb W6/32 and TP25.99 with FO-l clones A and C reflects the transfection of B2m gene, since the two MAbs did not react in binding assays with FO-1 cells transfected with pSV2neo gene alone (Fig. 6 ) and did not immunoprecipitate the two subunits of HLA class I antigens from these latter cells. After incubation with IFN-'y (1,000 U/ml) for 3 d FO-1 clones A and C displayed a marked increase in the level of 02-1 mRNA (Fig. 5) , in their reactivity with 125I-MAb W6/32 and TP25.99 in binding assays (Fig. 6 ) and in the intensity of HLA class I antigens detected by SDS-PAGE in the immunoprecipitates with MAb W6/32 (Fig. 7) . The increase induced by IFN-'y in the synthesis and expression of HLA class I antigens by FO-1 clones A and C is specific, since it induced only an increase in the HLA class I heavy chain mRNA in FO-1 cells transfected with the pSV2neo gene alone (results not shown) and did not change their lack ofreactivity with anti-HLA class I MAb W6/32 and TP25.99 (Fig. 6 ). I C . , (37) . DNA hybridization analysis with the probe derived from exons 2 and 3 (probe C, Fig. 4 (8, 9) . This is in striking contrast to the mouse MHC class I products encoded by the H-2D/H-2L region genes, which are unique in their capacity for transport to the cell surface in the apparent absence of 32-is (52) (53) (54) (56) (57) (58) . However, no mutant was isolated with a structural abnormality of B2m gene. Daudi cells, which are the only previously described human cell line with a spontaneous lack of 32-, synthesis (8, 12, 14) , transcribe the B2m gene, but do not translate /2-M mRNA (13, 59) because of a point mutation in the initiation codon (13) . Although not identified previously in human cell lines, the deletion of exon 1 from the B2m gene we have described is not unique of FO-1 cells, since a similar defect has been identified in four mouse cell lines derived from the C58 mouse thymoma cell line R1.1 by chemical or irradiation mutagenesis and subsequent selection with anti-TL antisera and complement (38, 60, 61) . Like FO-1 cells, the four mouse cell lines synthesize H-2 class I heavy chain but do not express H-2 class I antigens on the cell membrane, since defects in B2m gene preclude transcription of functional #2-t mRNA. Furthermore, like FO-1 cells, two mutants have only one copy of the chromosome which carries the B2m gene, and one mutant expresses H-2 class I antigens after having reacquired a functional B2m gene by hybridization with an antigenically distinct cell line (61) . Although different genomic rearrangements underlie the B2m gene abnormality in the four mutants, in each of them the defects in at least one B2m gene map to the same small DNA segment within the first intron. Thus, there may exist a hypermutable site within the first intron ofmouse B2m gene. What is the mechanism responsible for the deletion of B2m exon 1 DNA from the FO-I cell line? It has been established that the 5' region of the human B2m gene is a region of clustered CpG dinucleotides (37) . Such regions may be prone to genetic recombination. Thus, the CG-rich nature of the B2m gene may have contributed to the genetic rearrangement that has occurred in melanoma cell line FO-1. 
